Treatment of uterine cervical cancer;Arbre dećisionnel et thérapeutique des cancers du col de l'ut́erus

Revue du Praticien

Volumn 64, Issue 6, 2014, Pages 802-806

  Touboul, Cyril ^a   Skalli, Dounia ^a   Guillo, Éric ^a   Martin, Michel ^a   Mallaurie, Emmanuelle ^a   Mansouri, Dhouha ^a   Al Samad, Issam Abd ^a   Chabi, Naima ^a   Hospitel, Sylvie ^a   Koskas, Martin ^b   Haddad, Bassam ^a  

^a CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^b BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BRACHYTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CHEMORADIOTHERAPY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONSERVATIVE TREATMENT; LYMPH NODE DISSECTION; OVARY FUNCTION; PARAAORTIC LYMPH NODE; PREGNANCY; SENTINEL LYMPH NODE; SHORT SURVEY; UTERINE CERVIX CANCER; ADJUVANT THERAPY; ARTICLE; DECISION TREE; FEMALE; HUMAN; PATHOLOGY; UTERINE CERVIX; UTERINE CERVIX TUMOR;

CERVIX UTERI; CHEMORADIOTHERAPY; DECISION TREES; FEMALE; HUMANS; LYMPH NODE EXCISION; RADIOTHERAPY, ADJUVANT; UTERINE CERVICAL NEOPLASMS;

EID: 84903847251     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (11)

1. Haute Autorité de santé. Cancer invasif du col utérin. Guide ALD 30. Recommandations de la HAS, janvier 2010. http://www.has-sante.fr/portail/upload/docs/application/pdf/201002/ ald-30-gm-col-uterin-web-2010-02-12-09-57-34-599.pdf
2. Bonneau C, Cortez A, Lis R, et al. Lymphatic and nerve distribution throughout the parametrium. Gynecol Oncol 2013;131:708-13.
3. Rob L, Halaska M, Robova H. Nerve-sparing and individually tailored surgery for cervical cancer. Lancet Oncol 2010;11:292-301.
4. Uzan C, Gouy S, Pautier P, et al. La paramétrectomie est-elle nécessaire pour tous les cancers du col à un stade précoce? Gynecol Obstet Fertil 2009;37:504-9.
5. Lecuru F, Mathevet P, Querleu D, et al. Bilateral negative sentinel nodes accurately predict absence of lymph node metastasis in early cervical cancer: results of the SENTICOL study. J Clin Oncol 2011;29:1686-91.
6. Chemoradiotherapy for cervical cancer meta-analysis collaboration. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol I2008;26:5802-12.
7. Gouy S, Morice P, Narducci F, Uzan C, Gilmore J, Kolesnikov-Gauthier H, Querleu D, Haie-Meder C, Leblanc E. Nodal-staging surgery for locally advanced cervical cancer in the era of PET. Lancet Oncol I2012;13:e212-20.
8. Gouy S, Morice P, Narducci F, et al. Prospective multicenter study evaluating the survival of patients with locally advanced cervical cancer undergoing laparoscopic para-aortic lymphadenectomy before chemoradiotherapy in the era of positron emission tomography imaging. J Clin Oncol 2013;31:3026-33.
9. Haie-Meder C, Thomas L, Barillot I, Pommier P, Nickers P. Curiethérapie intégrant l'imagerie dans la prise en charge des patientes atteintes d'un cancer du col utérin. Cancer Radiother 2013;17:98-105.
10. Touboul C, Uzan C, Mauguen A, et al. Prognostic factors and morbidities after completion surgery in patients undergoing initial chemoradiation therapy for locally advanced cervical cancer. Oncologist 2010;15:405-15.
11. Mazeron R, Gilmore J, Dumas I, et al. Adaptive 3D image-guided brachytherapy: a strong argument in the debate on systematic radical hysterectomy for locally advanced cervical cancer. Oncologist 2013;18:415-22.